DALLAS—Essilor Instruments, a division of EssilorLuxottica (ESLOF) and Espansione Group have announced a long-term exclusive partnership for North America. Beginning Jan. 1, 2023, Essilor Instruments became the official distributor for the North American market of Espansione Group’s full portfolio of current solutions and future innovations. Espansione Group is an established player in the medtech industry focusing on ophthalmic and dermatological solutions to treat a number of conditions via patented, certified, and light-based technologies such as light modulation low-level light therapy, its signature photo-biomodulation technology, and optimal power energy intense pulsed light.

Jean-Christophe Paris, senior vice president, Essilor Instruments Americas, said, “We believe that Espansione Group’s new comprehensive set of technologies represent our best option to deliver great value to our customers. The company’s patented, light-based technologies have a strong track record when it comes to recognition and reputation with the scientific community, with dozens of papers published around their efficacy in managing inflammation-related dermatological and ophthalmic conditions, from dry eye disease caused by Meibomian glands dysfunction, acne, chalazia and rosacea. We are convinced that this new offering will create great value for the North American optometry and ophthalmology communities,” Paris said.  

Essilor Instruments is a worldwide leader in the development of modern solutions and technologies for eyecare professionals, providing an extensive range of equipment in categories such as finishing, refraction, diagnostics, vision screening and dispensing measurement devices.

Espansione Group is an established player in the medtech industry. The company invests heavily in researching and developing the Espansione Ecosystem of technologies and solutions to establish new paradigms in ophthalmology.

“We’re extremely humbled and proud of this agreement. Years of hard work building our ecosystem of technologies and solutions have paid off and enabled us to be trusted by a partner such as Essilor Instruments,” said Luca Trimigno, chief corporate development officer at Espansione Group.

“As we move into 2023 and continue developing our pipeline of innovation, we are looking forward to what is next. Espansione Group has the ambition of offering to both practitioners and patients, the best non-invasive technologies. We strive to put our clients’ satisfaction at the center of everything we do, and this mantra is perfectly aligned with the mission of Essilor Instruments.”

Professionals are encouraged to contact Essilor Instruments to obtain details on the portfolio of solutions in light therapy and digital imaging showcased with this partnership. To learn more visit www.essilorinstrumentsusa.com.